Superstring Capital Management LP
- SEC CIK
- 0001931118
- Latest filing
- Aug 14, 2026
Holdings in Q2 2025
Holdings as of Jun 30, 2025, filed Aug 14, 2025. Long positions only; changes compare share counts with Q1 2025.
- Positions
- 35
- +2 vs. Q1 2025
- Portfolio value
- $80.3M
- −$3.57M (−4.3%) vs. Q1 2025
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| Lakeshore Biopharma Co LtdG9845F208 | ORD SHS NEW | 30,792 | $31.4K | <0.1% | 00.0% | Unchanged | – |
| RAPTRAPT Therapeutics, Inc. | COM NEW | 26,034 | $208.3K | 0.3% | +26,034 | New | History |
| SYSo-Young International Inc. | SPONSORED ADS | 72,936 | $226.1K | 0.3% | +72,936 | New | History |
| IPSCCentury Therapeutics, Inc. | COM | 462,963 | $258.7K | 0.3% | 00.0% | Unchanged | History |
| KYTXKyverna Therapeutics, Inc. | COM | 142,542 | $437.6K | 0.5% | −48,745−25.5% | Reduced | History |
| BMEABiomea Fusion, Inc. | COM | 250,000 | $450.0K | 0.6% | +250,000 | New | History |
| WVEWave Life Sciences, Inc. | SHS | 70,242 | $456.6K | 0.6% | +70,242 | New | History |
| RCKTRocket Pharmaceuticals, Inc. | COM | 214,412 | $525.3K | 0.7% | +214,412 | New | History |
| OCULOcular Therapeutix, Inc | COM | 88,980 | $825.7K | 1.0% | +46,683+110.4% | Added | History |
| MLTXMoonLake Immunotherapeutics | CLASS A ORD | 17,623 | $831.8K | 1.0% | −14,522−45.2% | Reduced | History |
| LQDALiquidia Corp | COM NEW | 71,071 | $885.5K | 1.1% | +71,071 | New | History |
| ZBIOZenas BioPharma, Inc. | COM | 111,605 | $1.08M | 1.3% | 00.0% | Unchanged | History |
| TARAProtara Therapeutics, Inc. | COM STK | 360,000 | $1.09M | 1.4% | 00.0% | Unchanged | History |
| URGNUroGen Pharma Ltd. | COM | 87,912 | $1.20M | 1.5% | −335,720−79.2% | Reduced | History |
| Avidity Biosciences, Inc.05370A108 | COM | 47,037 | $1.34M | 1.7% | +24,766+111.2% | Added | – |
| UTHRUnited Therapeutics Corp | COM | 4,874 | $1.40M | 1.7% | +4,874 | New | History |
| INSMINSMED Inc | COM PAR $.01 | 14,571 | $1.47M | 1.8% | +14,571 | New | History |
| TECXTectonic Therapeutic, Inc. | COM | 79,058 | $1.57M | 2.0% | +28,312+55.8% | Added | History |
| CABACabaletta Bio, Inc. | COM | 1,060,764 | $1.61M | 2.0% | +601,792+131.1% | Added | History |
| BCAXBicara Therapeutics Inc. | COM | 189,699 | $1.76M | 2.2% | +189,699 | New | History |
| CYTKCytokinetics Inc | COM NEW | 61,103 | $2.02M | 2.5% | −11,889−16.3% | Reduced | History |
| ETNB89bio, Inc. | COM | 212,377 | $2.09M | 2.6% | +103,221+94.6% | Added | History |
| SVRASavara Inc | COM | 1,115,379 | $2.54M | 3.2% | +149,176+15.4% | Added | History |
| SLNOSoleno Therapeutics Inc | COM | 33,691 | $2.82M | 3.5% | +14,359+74.3% | Added | History |
| ORICOric Pharmaceuticals, Inc. | COM | 344,922 | $3.50M | 4.4% | −474,272−57.9% | Reduced | History |
| IONSIonis Pharmaceuticals Inc | COM | 98,267 | $3.88M | 4.8% | +98,267 | New | History |
| TVTXTravere Therapeutics, Inc. | COM | 276,474 | $4.09M | 5.1% | +38,987+16.4% | Added | History |
| BBIOBridgeBio Pharma, Inc. | COM | 96,766 | $4.18M | 5.2% | −87,156−47.4% | Reduced | History |
| JAZZJazz Pharmaceuticals plc | SHS USD | 44,107 | $4.68M | 5.8% | +44,107 | New | History |
| ZLABZai Lab Ltd | ADR | 134,895 | $4.72M | 5.9% | −160,052−54.3% | Reduced | History |
| RAREUltragenyx Pharmaceutical Inc. | COM | 130,422 | $4.74M | 5.9% | +130,422 | New | History |
| TERNTerns Pharmaceuticals, Inc. | COM | 1,286,681 | $4.80M | 6.0% | −70,472−5.2% | Reduced | History |
| NBIXNeurocrine Biosciences Inc | Stock | 40,608 | $5.10M | 6.4% | +40,608 | New | History |
| VRNAVerona Pharma plc | SPONSORED ADS | 68,982 | $6.52M | 8.1% | −27,839−28.8% | Reduced | History |
| COGTCogent Biosciences, Inc. | COM | 962,951 | $6.91M | 8.6% | +188,230+24.3% | Added | History |
Options (1)
Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.
| Security | Class | Puts | Calls |
|---|---|---|---|
| SLNOSoleno Therapeutics Inc | COM | $4.19M | – |
Sold out since Q1 2025 (11)
Positions held at the end of Q1 2025 that are gone from this filing.
| Security | Class | Shares in Q1 2025 | Value in Q1 2025 | % of portfolio in Q1 2025 | History |
|---|---|---|---|---|---|
| LEGNLegend Biotech Corp | SPONSORED ADS | 160,442 | $5.44M | 6.5% | History |
| PFEPfizer Inc | Stock | 196,164 | $4.97M | 5.9% | History |
| SMMTSummit Therapeutics Inc. | COM | 132,019 | $2.55M | 3.0% | History |
| SWTXSpringWorks Therapeutics, Inc. | COM | 54,216 | $2.39M | 2.9% | History |
| CAPRCapricor Therapeutics, Inc. | COM NEW | 241,192 | $2.29M | 2.7% | History |
| VSTMVerastem, Inc. | COM NEW | 336,363 | $2.03M | 2.4% | History |
| CRNXCrinetics Pharmaceuticals, Inc. | COM | 43,613 | $1.46M | 1.7% | History |
| MDGLMadrigal Pharmaceuticals, Inc. | COM | 3,815 | $1.26M | 1.5% | History |
| TSHATaysha Gene Therapies, Inc. | COM SHS | 755,599 | $1.05M | 1.3% | History |
| PCVXVaxcyte, Inc. | COM | 11,264 | $425.3K | 0.5% | History |
| SDGRSchrodinger, Inc. | COM | 14,114 | $278.6K | 0.3% | History |